Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation

Transplantation
T MiyauchiK Himeno

Abstract

To investigate the role of the liver in immune responses after small bowel transplantation, donor-specific splenocytes were infused perioperatively, via the portal vein, in a rat heterotopic small bowel transplant model. Heterotopic small bowel transplantation between the fully allogenic Brown Norway (BN) (RT1n) and Lewis (RT1[1]) strain rats were performed. We prepared donor splenocytes from BN or third-party WKA (RT1k) rat spleens for Lewis hosts and injected the splenocytes perioperatively via the host portal vein or the systemic vein. The hosts were treated with a short course of the immunosuppressive agent, FK506 (0.5 mg/kg, 0-3 days postoperatively), following the experimental protocols. Untreated Lewis hosts rejected BN small bowel grafts at 5.4+/-0.9 days (n=8). BN splenocytes given alone caused fatal graft-versus-host disease in six of eight animals, and two others died from graft rejection. FK506 alone did not significantly prolong graft survival (6.3+/-1.0 days, n=10). However, BN splenocytes injected via the portal vein, combined with FK506, prolonged graft survival to 12.7+/-2.1 days (n=12, P < 0.01) and 10 of 12 rats survived more than 70 days. This was donor antigen specific. BN splenocytes administered systemica...Continue Reading

References

Sep 1, 1992·Annals of Surgery·S TodoJ J Fung
Apr 1, 1986·American Journal of Surgery·A S Rosemurgy, W H Schraut
Aug 1, 1993·Journal of Pediatric Surgery·A G TzakisE Yunis
Jan 1, 1995·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·E KobayashiM Miyata
Oct 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·J R BATTISTO, J MILLER
Mar 1, 1946·Proceedings of the Society for Experimental Biology and Medicine·M W CHASE

❮ Previous
Next ❯

Citations

Dec 1, 1999·Transplantation Proceedings·G Remuzzi
Mar 17, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Christoph TroppmannRichard V Perez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.